Today's Information

Provided by: Savior Lifetec Corporation
SEQ_NO 2 Date of announcement 2022/06/08 Time of announcement 17:59:21
Subject 
 Announcement The Company and Shenzhen China
Resources GOSUN Pharmaceuticals signed an exclusive
sales contract for Ertapenem in the mainland market
Date of events 2022/06/08 To which item it meets paragraph 10
Statement 
1.Date of occurrence of the event:2022/06/08
2.Counterparty to the contract or commitment:
Shenzhen China Resources GOSUN Pharmaceuticals Co.,Ltd
3.Relationship with the Company:None
4.Starting and ending dates (or rescission date) of the
contract or commitment:From the date of signing the contract
5.Major content (not applicable where rescinded):
The company signed a sales contract with Shenzhen China Resources GOSUN
Pharmaceuticals, authorizing the company to exclusively sell the company's
ertapenem injection products in the mainland market.
6.Restrictive covenants (not applicable where rescinded):Privacy Policy
7.Commitment (not applicable where rescinded):None
8.Any other important agreement (not applicable where rescinded):None
9.Effect on company finances and business:
Accelerating the introduction of ertapenem into the Chinese mainland
market will help increase the global market share of the company's products
10.Concrete purpose/objective:Through this cooperation project, the company
will open a new milestone in the company's mainland market sales.
11.Any other matters that need to be specified:
It can only be sold after obtaining a drug certificate in cooperation with
the sales area. For financial or business information, please refer to the
information published by the Company on the Public Information Observatory.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Savior Lifetec Corporation published this content on 08 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2022 10:01:04 UTC.